11β-Hydroxysteroid dehydrogenase type 1: a tissue specific regulator of glucocorticoid response
The DOI matches its Crossref record; 398 of the 412 references it cites were found in a registry or an index.
Abstract
11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) interconverts inactive cortisone and active cortisol. Although bidirectional, in vivo it is believed to function as a reductase generating active glucocorticoid at a prereceptor level, enhancing glucocorticoid receptor activation. In this review, we discuss both the genetic and enzymatic characterization of 11beta-HSD1, as well as describing its role in physiology and pathology in a tissue-specific manner. The molecular basis of cortisone reductase deficiency, the putative "11beta-HSD1 knockout state" in humans, has been defined and is caused by intronic mutations in HSD11B1 that decrease gene transcription together with mutations in hexose-6-phosphate dehydrogenase, an endoluminal enzyme that provides reduced nicotinamide-adenine dinucleotide phosphate as cofactor to 11beta-HSD1 to permit reductase activity. We speculate that hexose-6-phosphate dehydrogenase activity and therefore reduced nicotinamide-adenine dinucleotide phosphate supply may be crucial in determining the directionality of 11beta-HSD1 activity. Therapeutic inhibition of 11beta-HSD1 reductase activity in patients with obesity and the metabolic syndrome, as well as in glaucoma and osteoporosis, remains an exciting prospect.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Cortisone and prednisone are inactive prohormones that must be reduced to cortisol or prednisolone by hepatic 11HSD1 to bind to and activate the glucocorticoid receptor (GR) (45, 587).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [587]
In the citing paper
“other health outcomes associated with better quality of life improved, including sleep apnoea136 and mobility137.”
From Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future (2014) · cites this paper as [136]
In the citing paper
“the glucocorticoid sensitivity may be different among the different individuals and among the different tissues in the same individual, due also to polymorphisms of both glucocorticoid receptor (25)(26)(27)(28) and 11-hydroxysteroid-dehydrogenase type 1 genes (29,30).”
From Diagnosis and Treatment of Subclinical Hypercortisolism (2011) · cites this paper as [29]
In the citing paper
“HSD11B2 functions exclusively as an oxidative enzyme, inactivating cortisol to cortisone [108].”
From Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: a comprehensive review (2019) · cites this paper as [108]
In the citing paper
“while 17OHP and cortisol can be either 5α- or 5β-reduced, 11-deoxycortisol and cortisone are predominantly 5β-reduced [108].”
From Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: a comprehensive review (2019) · cites this paper as [108]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Sapolsky, R. M., Romero, L. M., & Munck, A. U. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.1.0389 · Cited by 7,541 · cited 1×
“Immunomodulation represents an important facet of glucocorticoid physiology and inflammation therapy and is manifested by the regulation of cytokine production and immune cell function (324).”
Sapolsky, R. M. (2000) · Endocrine Reviews · doi:10.1210/er.21.1.55 · Cited by 7,533
A transgenic model of visceral obesity and the metabolic syndrome
Masuzaki, H., Paterson, J., Shinyama, H., Morton, N. M., Mullins, J. J., Seckl, J. R., & Flier, J. S. (2001) · Science · doi:10.1126/science.1066285 · Cited by 1,766 · cited 1×
“Mice overexpressing 11 -HSD1 under the aP2 promoter have enhanced adipocyte differentiation (as measured by increased fat cell size) as a consequence of increased adipose tissue corticosteroid concentrations (139) (see Section VII.”
Short-chain dehydrogenases/reductases (SDR)
Jörnvall, H., Persson, B., Krook, M., Atrian, S., Gonzalez-Duarte, R., Jeffery, J., & Ghosh, D. (1995) · Biochemistry · doi:10.1021/bi00018a001 · Cited by 1,249 · cited 3×
“Also known as short-chain alcohol dehydrogenases (35) or sec (secondary) alcohol dehydrogenases (36), members of this family were originally classified as having 250–300 residues (classical family) with an N-terminal cofactor-binding domain and a centrally located active site, although some enzymes now have more than…”
Edwards, C. R. W., Burt, D., Mcintyre, M. A., De Kloet, E. R., Stewart, P. M., Brett, L., Sutanto, W. S., & Monder, C. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90742-8 · Cited by 1,068
Self-citationCole, T. J., Blendy, J. A., Monaghan, A. P., Krieglstein, K., Schmid, W., Aguzzi, A., Fantuzzi, G., Hummler, E., Unsicker, K., & Schütz, G. (1995) · Genes & Development · doi:10.1101/gad.9.13.1608 · Cited by 946 · cited 1×
“Within the fetal rat lung, corticosteroids increased 11-oxoreductase activity, which in turn resulted in an increase in surfactant synthesis (71), a glucocorticoiddependent process (336) essential for normal lung maturation.”
Impaired Energy Homeostasis in C/EBPα Knockout Mice
Wang, N.-D., Finegold, M. J., Bradley, A., Ou, C. N., Abdelsayed, S. V., Wilde, M. D., Taylor, L. R., Wilson, D. R., & Darlington, G. J. (1995) · Science · doi:10.1126/science.7652557 · Cited by 929
Kotelevtsev, Y., Holmes, M. C., Burchell, A., Houston, P. M., Schmoll, D., Jamieson, P., Best, R., Brown, R., Edwards, C. R. W., Seckl, J. R., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14924 · Cited by 858
Stewart, P., Valentino, R., Wallace, A. M., Burt, D., Shackleton, C. L., & Edwards, C. W. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91014-2 · Cited by 803
Self-citationANTI-ESCHERICHIA COLI ALPHA-HAEMOLYSIN IN CONTROL AND PATIENT SERA
Emody, L., Batai, I., Kerényi, M., Székely, J., & Polyak, L. (1982) · The Lancet · doi:10.1016/s0140-6736(82)90183-0 · Cited by 800
Research works printed but not linked: 6
- Bush, 1969, 11β-Hydroxysteroid dehydrogenase: contrast between studies in vivo and studies in vitro., Adv Biosci, 3, 23
- Taylor, 1990, Corticosteroid 11-reductase deficiency: steroid studies in a further family, J Clin Invest, 13, P238
- Burtt, 2003, Haplotype-based association studies of HSD11B1 and abdominal obesity, 117
- Bujalska, 2000, Glucocorticoids, 11β-hydroxysteroid dehydrogenase and obesity, 158
- Taylor, 1984, Cortisone reductase deficiency: evidence for a new inborn error in metabolism of adrenal steroids, J Endocrinol, 102, 89
- Savage, 1991, Increased metabolic clearance of cortisol in corticosteroid 11-reductase deficiency, J Endocrinol, 129, 219
Cited by
Items 701–800 of 1,000
The dual role of glucocorticoid regeneration in inflammation at parturition
Ling, L., Zhou, Q., Zhang, F., Lei, W., Li, M., Lu, J., Wang, W., Sun, K., & Ying, H. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1459489 · Cited by 8
Barkataki, S., & Aluru, N. (2013) · Journal of Aquaculture Research & Development · doi:10.4172/2155-9546.s2-001 · Cited by 8
Prasad, S. M. V. K., Muralidhar, M. N., Dinesh Yadav, D. M., Kondeti, S., & Kalashikam, R. R. (2020) · Steroids · doi:10.1016/j.steroids.2020.108653 · Cited by 8
Progesterone stimulates cortisol production in the maturing bovine cumulus-oocyte complex
Anbo, N., Suzuki, A., MUKANGWA, M., Takahashi, R., Muranishi, Y., & TETSUKA, M. (2022) · Theriogenology · doi:10.1016/j.theriogenology.2022.06.019 · Cited by 8
Meng, Z., Bao, X., Zhang, M., Wei, S., Chang, W., Li, J., Chen, L., & Nyomba, B. L. G. (2013) · Journal of Diabetes Research · doi:10.1155/2013/218102 · Cited by 8
Shimizu, N., Yoshikawa, N., Wada, T., Handa, H., Sano, M., Fukuda, K., Suematsu, M., Sawai, T., Morimoto, C., & Hirotoshi, H. (2008) · Molecular Endocrinology · doi:10.1210/me.2008-0101 · Cited by 8
Persistent Comorbidities in Cushing’s Syndrome after Endocrine Cure
Resmini, E. (2014) · Advances in Endocrinology · doi:10.1155/2014/231432 · Cited by 9
Nakata, T., Fujita, A., Umeda, M., Yoshida, H., Inami, K., Masuzaki, H., & Sawai, H. (2016) · SpringerPlus · doi:10.1186/s40064-016-1679-6 · Cited by 8
Genetics of adrenocortical disease: an update
Bar-Lev, A., & Annes, J. P. (2012) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e328352f013 · Cited by 9
Role of tissue‐specific steroid metabolism in oral disease: Is there any clinical implication?
Cirillo, N. (2018) · Oral Diseases · doi:10.1111/odi.12767 · Cited by 8
Vulto, A., Minović, I., de Vries, L. V., Timmermans, A. C., van Faassen, M. H. J. R., Neto, A. W. G., Touw, D. J., de Jong, M. F. C., van Beek, A. P., Dullaart, R. P. F., et al. (2020) · Clinical Transplantation · doi:10.1111/ctr.13824 · Cited by 9
“Cortisol excretion (nmol/24 h) 30 [15-57] 332 [244-445] <.”
InfluentialGuan, H., Wang, Y., Li, H., Zhu, Q., Li, X., Liang, G., & Ge, R.-S. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.594437 · Cited by 8
Glucocorticoid-Induced Leucine Zipper (GILZ) in Cardiovascular Health and Disease
Cappetta, D., Bereshchenko, O., Cianflone, E., Rossi, F., Riccardi, C., Torella, D., Berrino, L., Urbanek, K., Angelis, A. D., & Bruscoli, S. (2021) · Cells · doi:10.3390/cells10082155 · Cited by 9
Robb, G. R., Boyd, S., Davies, C. D., Dossetter, A. G., Goldberg, F. W., Kemmitt, P. D., Scott, J. S., & Swales, J. G. (2015) · MedChemComm · doi:10.1039/c5md00043b · Cited by 8
Katz, A., Heiblum, R., Meidan, R., & Robinzon, B. (2007) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2007.10.002 · Cited by 8
Ahmad, F., Soelaiman, I. N., Ramli, E. S. M., Hooi, T. M., & Suhaimi, F. H. (2011) · Clinics · doi:10.1590/s1807-59322011000500023 · Cited by 8
“In rat adipose tissue, 11b-HSD1 acts predominantly as a reductase enzyme; it catalyzes the conversion of 11-dehydrocorticosterone to corticosterone, which results in hypertrophy of adipocytes.(6) The dehydrogenase activity of 11b-HSD1 converts corticosterone to 11-dehydrocorticosterone, which results in hyperplasia of…”
Upregulation of Hepatic 11β-Hydroxysteroid Dehydrogenase-1 Expression in Calcium-Deficient Rats
Takaya, J., Iharada, A., Okihana, H., & Kaneko, K. (2011) · Annals of Nutrition and Metabolism · doi:10.1159/000332915 · Cited by 9
An accurate, non-invasive approach to diagnose Cushing’s syndrome in at-risk populations
Cardoso, E. M. L., Arregger, A. L., Monardes, G., & Contreras, L. N. (2013) · Steroids · doi:10.1016/j.steroids.2013.02.005 · Cited by 8
“This worrisome clinical scenario might be ascribed to glucocorticoid sensitivity, which may differ among individuals, between tissues of the same individual or as a consequence of polymorphisms in the genes encoding the glucocorticoid receptor and 11-beta-hydroxysteroid-dehydrogenase type 1 [25,26].”
Zhang, B., Jia, Y., Yan, J., Zhou, J., Rustamova, N. A., Cao, J., & Huang, G. (2025) · Chemistry & Biodiversity · doi:10.1002/cbdv.202501153 · Cited by 7
Buttgereit, F., Everding, A., Andreica, I., Kellner, H., Schuch, F., Weyand, C. M., Stewart, P. M., Merkel, P. A., Dejaco, C., Czerwiec, F. S., et al. (2025) · Annals of the Rheumatic Diseases · doi:10.1016/j.ard.2025.10.015 · Cited by 7
Self-citationSun, D., Ye, Q., Yan, X., Rew, Y., Fan, P. W., He, X., Jiang, M., McMinn, D. L., Monshouwer, M., Tu, H., et al. (2014) · ACS Medicinal Chemistry Letters · doi:10.1021/ml500331y · Cited by 7
Adverse Childhood Experiences: Associations with a Blunted Cortisol Stress Response During Pregnancy
Carbone, J. T., Hicks, L. M., Brown, S., Saini, E. K., & Dayton, C. J. (2023) · Maternal and Child Health Journal · doi:10.1007/s10995-023-03651-2 · Cited by 7
“Specifically, cortisol peaks roughly 25–30 min after exposure to an acute stressor and has a half-life of anywhere from 70 to 120 min (Berens & Nelson, 2009; Boucher & Plusquellec, 2019; Tomlinson et al., 2004).”
Chowdhury, S., Grimm, L., Gong, Y. J. K., Wang, B., Li, B., Srikant, C. B., Gao, Z., & Liu, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136656 · Cited by 8
Schmidt, M., & Straub, R. H. (2014) · NeuroImmunoModulation · doi:10.1159/000362725 · Cited by 7
Randall, M. J., Kostin, S. F., Burgess, E. J., Hoyt, L. R., Ather, J. L., Lundblad, L. K. A., & Poynter, M. E. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00236 · Cited by 7
“11β-HSD1, on the other hand, acts predominantly as an oxidoreductase, converting inactive 11-keto to active 11-hydroxylated corticosteroids (18, 21, 22).”
Genetic variants of the HSD11B1 gene promoter may be protective against polycystic ovary syndrome
Grolmusz, V. K., Ács, O. D., Feldman, K., Szappanos, Á., Stenczer, B., Fekete, T., Szendei, G., Reismann, P., Rácz, K., & Patócs, A. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3473-2 · Cited by 8
McCoull, W., Augustin, M. A., Blake, C., Ertan, A., Kilgour, E., Krapp, S., Moore, J. E., Newcombe, N. J., Packer, M. J., Rees, A., et al. (2013) · MedChemComm · doi:10.1039/c3md00234a · Cited by 7
Ju, R., Wu, W., Tang, Q., Wu, D., Xia, Y., Wu, J., & Wang, X. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140326 · Cited by 7
Khashana, A., & Ahmed, E. (2017) · Pediatrics & Neonatology · doi:10.1016/j.pedneo.2016.09.010 · Cited by 7
“Regulation of 11- bHSD1 expression is important since the enzyme is believed to increase local glucocorticoid signaling as it converts inactive cortisone to active cortisol.(33,34) Newborn infants with septicemia and therapy-resistant hypotension also had very high DHEA levels, suggesting an analogous limitation in co…”
Kniss, D. A., & Summerfield, T. L. S. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00883 · Cited by 7
“…co-incubated with cytokine and progestin, including the steroid hormone receptor chaperone FK506-binding protein 5 (FKBP5) (Storer et al., 2011) and 11β-HSD1, the enzyme that converts biologically inert cortisone into bioactive cortisol (Tomlinson et al., 2004; Chapman K. et al., 2013; Figure 4A).”
Brix, J. M., Tura, A., Herz, C. T., Feder, A., Krzizek, E.-C., Parzer, V., Pacini, G., & Ludvik, B. H. (2021) · Obesity Facts · doi:10.1159/000517766 · Cited by 8
Oyola, M. G., Malysz, A. M., Mani, S. K., & Handa, R. J. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-802114-9.00013-5 · Cited by 7
Udagawa, S., Sakami, S., Takemura, T., Sato, M., Arai, T., Nitta, A., Aoki, T., Kawai, K., Iwamura, T., Okazaki, S., et al. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.01.090 · Cited by 7
Boudon, S. M., Heidl, M., Vuorinen, A., Wandeler, E., Campiche, R., Odermatt, A., & Jackson, E. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2018.09.009 · Cited by 7
High abdominal adiposity and low phase angle in overweight renal transplant recipients
Ferreira, T. D. S., Silva, M. I. B., da Costa, M. S., Pontes, K. S. D. S., Castro, F. G., Antunes, V. P., Rosina, K. T. D. C., Barreto, A. P. M. M., Souza, E., & Klein, M. R. S. T. (2019) · Clinical Transplantation · doi:10.1111/ctr.13654 · Cited by 7
Hillier, S. G., Rae, M. T., & Gubbay, O. (2008) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-69080-3_16 · Cited by 7
Metabolic Dysfunction in Idiopathic Intracranial Hypertension: Current Theories and Updates
Li, H., Liu, L., Zhou, Y., Jiang, H., Zhang, W., Zhou, C., Wu, C., Zhou, C. Y., & Ji, X. (2024) · Aging and Disease · doi:10.14336/ad.2024.1147 · Cited by 10
“11β -HSD1 primarily serves as a reductase, converting inactive glucocorticoids, such as cortisone, into their active form, cortisol, thereby promoting adipocyte differentiation and hepatic glucose output in adipose tissue [201, 202] .”
Yan, X., Jiang, R., Tang, Q., Tan, Q., Cooper, M. S., & Wang, Y. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.145753 · Cited by 6
Self-citationCharacterization of a Rat Multi-Cell Type 3D-Liver Microtissue System
Odermatt, A. (2013) · Journal of Tissue Science & Engineering · doi:10.4172/2157-7552.1000130 · Cited by 7
“Moreover, a rapid decline of 11β-HSD1 reductase activity is observed upon cultivating freshly isolated primary hepatocytes, with almost complete loss after 48 h in culture [27].”
Loerz, C., Staab-Weijnitz, C. A., Huebbe, P., Giller, K., Metges, C. C., Rimbach, G. H., & Maser, E. (2017) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2017.02.018 · Cited by 6
Glucocorticoids modify intracranial pressure in freely moving rats
Westgate, C. S. J., Israelsen, I. M. E., Kamp‐Jensen, C., Jensen, R., & Eftekhari, S. (2023) · Fluids and Barriers of the CNS · doi:10.1186/s12987-023-00439-y · Cited by 6
“GCs elicit a multitude of antiinflammatory and catabolic processes mediated through the GC activating enzyme 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) converting cortisone (dehydrocorticosterone in rodents) to cortisol (corticosterone (CORT) in rodents) [5, 6].”
Vratarić, M., Šenk, V., Bursać, B. N., Gligorovska, L., Ignjatović, Đ., Kovačević, S., Veličković, N. A., & Djordjevic, A. D. (2021) · BioFactors · doi:10.1002/biof.1802 · Cited by 7
Yang, L., Sun, J., Zhang, Y., Guo, X., & Zhao, G. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.942326 · Cited by 7
“11β-HSD1 (HSD11B1) is the major glucocorticoid-modifying enzyme in bone that is expressed in human osteoblasts in vivo and affects osteoblastic proliferation and differentiation (Tomlinson et al., 2004).”
Chavira-Suárez, E., Reyes‐Castro, L. A., López-Tenorio, I. I., Vargas-Hernández, L., Rodríguez-González, G. L., Chavira, R., Zárate-Segura, P. B., Domínguez‐López, A., Vadillo‐Ortega, F., & Zambrano, E. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.892315 · Cited by 6
Duan, X., Xin, H., & Yan, H. (2014) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b14-00070 · Cited by 6
Zhang, L., Chen, J., Ning, M., Zou, Q., Leng, Y., & Shen, J. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.02.095 · Cited by 6
Adamts1 responds to systemic cues and gates adipogenesis
Wong, J. C., & Feldman, B. J. (2017) · Adipocyte · doi:10.1080/21623945.2017.1322746 · Cited by 6
Vagnerová, K., Loukotová, J., Ergang, P., Musílková, J., Mikšík, I., & Pácha, J. (2011) · Steroids · doi:10.1016/j.steroids.2011.02.008 · Cited by 6
Circulating 11β‐Hydroxysteroid Dehydrogenase Type 1 mRNA and Cardiovascular Risk Factors
Bakir, M. A., Butt, A. N., & Swaminathan, R. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1448.007 · Cited by 6
Inder, W. J., Obeyesekere, V. R., Jang, C., & Saffery, R. (2012) · Clinical Epigenetics · doi:10.1186/1868-7083-4-24 · Cited by 6
Zhang, W., Wang, Y., Wei, Z. C., Chang, G., Luo, Q., Abudusailamu, N., Nurula, M., Tao, S., Li, H., & Chen, Y. (2019) · Springer eBooks · doi:10.1007/978-981-15-0591-1_9 · Cited by 5
New Approaches to the Treatment of Hypercortisolism
Pofi, R., Alcubierre, D. D., Dong, J., & Tomlinson, J. (2024) · Annual Review of Medicine · doi:10.1146/annurev-med-071723-044849 · Cited by 6
Self-citationRobinzon, B., & Prough, R. A. (2009) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2009.04.010 · Cited by 5
Rethinking chronic obstructive pulmonary disease
Tonello, A., & Poli, G. (2010) · Medical Hypotheses · doi:10.1016/j.mehy.2010.10.039 · Cited by 5
Could dehydroepiandrosterone (DHEA) be a novel target for depression?
Souza‐Teodoro, L. H., Andrade, L. H., & Carvalho, L. A. (2022) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2022.100340 · Cited by 5
Charmandari, E., Kino, T., & Chrousos, G. P. (2012) · Humana Press eBooks · doi:10.1007/978-1-60761-548-4_4 · Cited by 6
Suzuki, M., Funasaka, N., Sato, Y., Inamori, D., Watanabe, Y., Ozaki, M., Hosono, M., Shindo, H., Kawamura, K., Tatsukawa, T., et al. (2024) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2024.114516 · Cited by 5
Boullu‐Ciocca, S., Tassistro, V., Dutour, A., & Grino, M. (2015) · Endocrine · doi:10.1007/s12020-015-0657-z · Cited by 5
Importance of the 11β-hydroxysteroid dehydrogenase enzyme in clinical disorders
Feldman, K., Likó, I., Nagy, Z., Szappanos, Á., Grolmusz, V. K., Tóth, M., Rácz, K., & Patócs, A. (2013) · Orvosi Hetilap · doi:10.1556/oh.2013.29558 · Cited by 5
Mondok, Á., Varga, I., Gláz, E., Szücs, N., Tóth, M., Patócs, A., Bekő, G., & Rácz, K. (2009) · Steroids · doi:10.1016/j.steroids.2009.03.003 · Cited by 5
SEXUAL PRECOCITY: A HISTORICAL PERSPECTIVE AND UPDATE
Root, A. W. (2005) · Fetal and Pediatric Pathology · doi:10.1080/15227950590961207 · Cited by 5
Unassisted successful pregnancy in a case of Addison′s disease with recurrent pregnancy loss
Ganie, M., Bhat, R., Irfan-ul-Qayoom, Dangroo, M. A., Kotwal, S. K., Bhat, M., Ahmed, S., Hassan, S., & Shah, Z. A. (2012) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.95747 · Cited by 5
“[7] Thyroid hormone stimulates the activity of hepatic ∆4 5-steroid reductases, and it decreases the reductase activity of hepatic 11 hydroxysteroid dehydrogenase (11 HSD) type 1, thereby decreasing conversion of cortisone, which is biologically inactive, to cortisol.[8-10] The activity of 11 HSD type 1 reductase acti…”
Sola-Carvajal, A., García-García, M. I., Sánchez-Carrón, G., García‐Carmona, F., & Sánchez‐Ferrer, Á. (2012) · Biochimie · doi:10.1016/j.biochi.2012.06.018 · Cited by 5
Oleoyl-estrone increases adrenal corticosteroid synthesis gene expression in overweight male rats
Romero, M. D. M., Vilà, R., Fernández–Löpez, J., Esteve, M., & Alemany, M. (2009) · Steroids · doi:10.1016/j.steroids.2009.09.009 · Cited by 5
Evidence for glucocorticoid-mediated hypertension after uninephrectomy
Huesler, C., Lauterburg, M., Frey, B. M., & Frey, F. J. (2013) · Physiological Reports · doi:10.1002/phy2.101 · Cited by 5
An, G., Liu, W., Katz, D. A., Marek, G. J., Awni, W. M., & Dutta, S. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.049742 · Cited by 5
Šimůnková, K., Hampl, R., Hill, M., Kříž, L., Vrbíková, J., Kvasničková, H., & Vondra, K. (2011) · Physiological Research · doi:10.33549/physiolres.932079 · Cited by 5
“…Šimůnková et al. Vol. 60 isoenzyme, was assessed by cortisone acetate test, believed to provide sufficient information for clinical research (Andrews et al. 2002, Rask et al. 2002, Westerbacka et al. 2003, Tomlinson et al. 2004, Putignano et al. 2004, Stewart et al. 2005, Mai et al. 2007).”
Dual-release Hydrocortisone in Addison’s Disease – A Review of the Literature
Giordano, R., Guaraldi, F., Berardelli, R., Karamouzis, I., Angelo, V. D., Zichi, C., Grottoli, S., Ghigo, E., & Arvat, E. (2010) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2014.10.01.75 · Cited by 5
Chen, X., Dong, Y., Cao, S., Li, X., Wang, Z., Chen, R., & Ge, R. (2016) · Pharmacology · doi:10.1159/000445213 · Cited by 5
Oral pharmacokinetics and in-vitro metabolism of metyrapone in male rats
Murata, H., Higuchi, T., & Otagiri, M. (2016) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12560 · Cited by 5
Current Computational Approaches at Astrazeneca for Solid‐State and Property Predictions
Lill, S. O. N., Schantz, S., Broo, V., & Broo, A. (2016) · Wiley eBooks · doi:10.1002/9781118700686.ch7 · Cited by 5
Miceli, D. D., Abiuso, A. M. B., Vidal, P. N., Gallelli, M. F., Pignataro, O. P., & Castillo, V. A. (2018) · Open Veterinary Journal · doi:10.4314/ovj.v8i1.13 · Cited by 5
Veríssimo, G., Bast, A., & Weseler, A. R. (2018) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2018.06.024 · Cited by 5
Dasenaki, M. E., Papatzani, M., Gounari, E. A., Magnisali, P., Papadopoulou‐Marketou, N., Kanaka‐Gantenbein, C., Moutsatsou, P., & Τhomaidis, Ν. S. (2019) · Analytical Letters · doi:10.1080/00032719.2019.1602629 · Cited by 5
Guzmán, V., Kenny, R. A., & Feeney, J. C. (2020) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2020.104701 · Cited by 6
Aldosterone Increases Vascular Permeability in Rat Skin
Aleksiejczuk, M., Gromotowicz‐Poplawska, A., Marcińczyk, N., Stelmaszewska, J., Dzięcioł, J. B., & Chabielska, E. (2022) · Cells · doi:10.3390/cells11172707 · Cited by 5
Nouchi, Y., Munetsuna, E., Yamada, H., Yamazaki, M., Ando, Y., Mizuno, G., Fujii, R., Kageyama, I., Wakasugi, T., Sakakibara, T., et al. (2022) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1936-3310 · Cited by 5
Wu, N., Katz, D. A., & An, G. (2023) · Clinical Pharmacokinetics · doi:10.1007/s40262-023-01278-8 · Cited by 5
Zhang, X., Zhou, Y., Shen, Y., Du, L., Chen, J., Leng, Y., & Shen, J. (2009) · Acta Pharmacologica Sinica · doi:10.1038/aps.2009.118 · Cited by 5
Synergistic Effects of Ageing and Stress on Neutrophil Function
Lord, J. M., Phillips, A. C., & Arlt, W. (2009) · Springer eBooks · doi:10.1007/978-1-4020-9063-9_24 · Cited by 6
Religion, spirituality, and DNA methylation in HPA-axis genes among Hispanic/Latino adults
Zhen‐Duan, J., Canenguez, K. M., Wilson, A. E., Gu, Y., Valluri, H. G., Chavez, A. D., Argentieri, M. A., Schachter, A. B., Wu, H., Baccarelli, A., et al. (2024) · Epigenomics · doi:10.1080/17501911.2024.2442293 · Cited by 5
Adrenal–adipose tissue crosstalk in health and disease
Jiang, M., Stifel, U., Blüher, M., Lefèbvre, H., Bornstein, S. R., & Bechmann, N. (2025) · European Journal of Endocrinology · doi:10.1093/ejendo/lvaf252 · Cited by 4
Dujić, T., Ostanek, B., Marc, J., Čaušević, A., & Mlinar, B. (2010) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2010.0105 · Cited by 4
Glucocorticoids, Inflammation, and Bone
Ng, K. W., & Martin, T. J. (2012) · Springer eBooks · doi:10.1007/978-1-4471-2745-1_7 · Cited by 5
Weber, R. J., Kawaja, C., Wallerstein, R. J., Kunwar, S. M., & Liu, C. (2024) · JCEM Case Reports · doi:10.1210/jcemcr/luae158 · Cited by 4
Wang, L., Meng, X., Tang, Y., & Hao, Y. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1418357 · Cited by 5
Morris, D. J., Latif, S. A., Lo, Y. H., Abrampah, K., Brem, A. S., Litchfield, W. R., & Williams, G. H. (2008) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2008.01.001 · Cited by 4
Nakata, T., Umeda, M., Masuzaki, H., & Sawai, H. (2016) · BMC Oral Health · doi:10.1186/s12903-016-0303-z · Cited by 4
Discovery of camphor-derived pyrazolones as 11β-hydroxysteroid dehydrogenase type 1 inhibitors
Gillespie, P., Pietranico‐Cole, S. L., Myers, M. C., Bilotta, J. A., Conde‐Knape, K., Fotouhi, N., Goodnow, R. A., Guertin, K. R., Hamilton, M. M., Haynes, N.-E., et al. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.04.049 · Cited by 4
Ebrahimi, F., Urwyler, S. A., Schüetz, P., Müeller, B., Bernasconi, L., Neyer, P. J., Donath, M. Y., & Christ‐Crain, M. (2019) · Endocrine Connections · doi:10.1530/ec-19-0201 · Cited by 5
Gene variants and treatment outcomes in antineutrophil cytoplasmic antibody-associated vasculitis
Hessels, A. C., Sanders, J., Rutgers, A., & Stegeman, C. A. (2020) · The Pharmacogenomics Journal · doi:10.1038/s41397-020-0176-z · Cited by 4
Inflammation and osteosarcopenia
Huang, Y., Li, Y., & Leng, S. X. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-820088-9.00013-5 · Cited by 4
Hernández-Bustamante, I., Plantamura, Y. S., Mata‐Espinosa, D., Reyes‐Chaparro, A., Bini, E. I., Torre-Villalvazo, I., Tovar, A. R., Barrios‐Payán, J., Marquina‐Castillo, B., Hernández‐Pando, R., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1055430 · Cited by 8
Ligand Regulation and Nuclear Receptor Action
Hewison, M. (2010) · Springer eBooks · doi:10.1007/978-90-481-3303-1_16 · Cited by 5
Self-citationLa 11β-hydroxystéroïde déshydrogénase de type 1 – 1 partie
Iovino, A., & Scheen, A. J. (2009) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(09)73299-7 · Cited by 4
Variants of 11β-hydroxysteroid dehydrogenase (HSD11B) gene type 1 and 2 in Chinese obese adolescents
Ruan, L. L., Xu, J. H., Wang, C. L., & Zou, C. C. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-014-0075-8 · Cited by 4
Glucocorticoid-induced osteoporosis
Mazziotti, G., Giustina, A., CANALIS, E. M., & Bilezikian, J. P. (2011) · doi:10.1093/med/9780199235292.003.0497 · Cited by 4
QSAR Study of Arylsulfonylpiperazine Inhibitors of 11β-HSD1 by GA-MLR, GA-PLS and GA-ANN
Nekoei, M., Goudarzi, N., Nekoei, S., & Mohammadhosseini, M. (2014) · Analytical Chemistry Letters · doi:10.1080/22297928.2013.856167 · Cited by 4
GOODMAN, H. M. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-373975-9.00004-5 · Cited by 5
Iovino, A., Paquot, N., & Scheen, A. J. (2010) · JMIG · doi:10.53738/revmed.2010.6.260.1608 · Cited by 4
Metadata
- Authors
- Tomlinson, J. W., Walker, E. A., Bujalska, I. J., Draper, N., Lavery, G. G., Cooper, M. S., Hewison, M., & Stewart, P. M.
- Affiliations
- Queen Elizabeth Hospital Birmingham (GB)
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2004-10-01
- Volume
- 25
- Issue
- 5
- Pages
- 831-866
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2016125985
- Semantic Scholar
- 7653c899826b606d61172864887c634e9d76851b
- Cited by
- 969
- References
- 412
- Citations by year
- 2026: 17 · 2025: 22 · 2024: 25 · 2023: 23 · 2022: 32 · 2021: 30 · 2020: 27 · 2019: 34 · 2018: 30 · 2017: 33 · 2016: 38 · 2015: 43 · 2014: 55 · 2013: 65 · 2012: 70
- FWCI
- 7.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- 11β-hydroxysteroid dehydrogenase type 1, glucocorticoid metabolism, hexose-6-phosphate dehydrogenase, NADPH cofactor, tissue-specific gene regulation, obesity, metabolic syndrome, glaucoma, osteoporosis, 11β-HSD1 inhibition
- MeSH terms
- Amino Acid Sequence, Animals, Carbohydrate Dehydrogenases, Cloning, Molecular, Cortisone Reductase, Enzyme Inhibitors, Glaucoma, Glucocorticoids, Humans, Hydrocortisone, Molecular Sequence Data, Mutation, NADP, Obesity, Organ Specificity, Osteoporosis, Recombinant Proteins, Substrate Specificity, Transcription, Genetic, Gene Expression Regulation, Enzymologic, Sequence Alignment, 11-beta-Hydroxysteroid Dehydrogenase Type 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.